The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer

Radiotherapy and Oncology

Volumn 105, Issue 2, 2012, Pages 193-197

  Jain, Suneil ^a   Loblaw, D Andrew ^a   Morton, Gerard C ^a   Danjoux, Cyril ^a   Szumacher, Ewa ^a   Chu, William ^a   Chung, Hans T ^a   Vesprini, Danny ^a   Sahgal, Arjun ^a   Zhang, Liying ^a   Deabreu, Andrea ^a   Cheung, Patrick C F ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Acute toxicity; Bladder filling; IMRT; Pelvic radiotherapy; Prostate cancer

Indexed keywords

GONADORELIN AGONIST;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLADDER FILLING; CANCER RADIOTHERAPY; CONTROLLED STUDY; ELECTIVE PELVIC NODAL IRRADIATION; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INJURY; RISK REDUCTION; TREATMENT PLANNING; URINARY FREQUENCY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PELVIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; URINARY BLADDER;

EID: 84871292414     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.09.020     Document Type: Article

References (19)

1. S. Arcangeli, B. Saracino, and M.G. Petrongari Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area Radiother Oncol 84 2007 148 155
2. D. Wolff, F. Stieler, and G. Welzel Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer Radiother Oncol 93 2009 226 233
3. C.M. Nutting, D.J. Convery, and V.P. Cosgrove Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer Int J Radiat Oncol Biol Phys 48 2000 649 656
4. Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary analysis of 3DCRT vs IMRT on the high dose arm of the RTOG 0126 prostate cancer trial: toxicity report. Presented at the 53rd annual meeting of the American Society of Radiation Oncology, October 2-6, 2011, Miami, FL, 2012.
5. A. Al-Mamgani, W.D. Heemsbergen, S.T. Peeters, and J.V. Lebesque Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer Int J Radiat Oncol Biol Phys 73 2009 685 691
6. H. Quon, P.C.F. Cheung, and D.A. Loblaw Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity Int J Radiat Oncol Biol Phys 82 2011 898 905
7. H.A. Shih, M. Harisinghani, A.L. Zietman, J.A. Wolfgang, M. Saksena, and R. Weissleder Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy Int J Radiat Oncol Biol Phys 63 2005 1262 1269
8. C.A.F. Lawton, J. Michalski, and I. El-Naqa RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
9. S. Myrehaug, G. Chan, and T. Craig A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 82 2012 e657 e662
10. N.K. Sharma, T. Li, D.Y. Chen, A. Pollack, E.M. Horwitz, and M.K. Buyyounouski Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer Int J Radiat Oncol Biol Phys 80 2011 437 444
11. P. Dirix, K. Haustermans, S. Junius, R. Withers, R. Oyen, and H. Van Poppel The role of whole pelvic radiotherapy in locally advanced prostate cancer Radiother Oncol 79 2006 1 14
12. M. Roach 3rd, M. DeSilvio, and R. Valicenti Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the radiation therapy oncology group 9413 trial Int J Radiat Oncol Biol Phys 66 2006 647 653
13. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
14. P.W. McLaughlin, A. Wygoda, and W. Sahijdak The effect of patient position and treatment technique in conformal treatment of prostate cancer Int J Radiat Oncol Biol Phys 45 1999 407 413
15. M. Pinkawa, B. Asadpour, B. Gagel, M.D. Piroth, R. Holy, and M.J. Eble Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder Int J Radiat Oncol Biol Phys 64 2006 856 861
16. M. Pinkawa, K. Fischedick, B. Asadpour, B. Gagel, M.D. Piroth, and M.J. Eble Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume Int J Radiat Oncol Biol Phys 64 2006 835 841
17. V. Fonteyne, G. Villeirs, N. Lumen, and G. De Meerleer Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer Radiother Oncol 92 2009 42 47
18. G.C. Morton, D.A. Loblaw, and R. Sankreacha Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life Int J Radiat Oncol Biol Phys 77 2010 811 817
19. C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167